Clinical Trial Update: A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the long-term efficacy and safety of BMN 110 in patients with Mucopolysaccharidosis IVA (Morquio A) was terminated. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Iva

Drugs mentioned

• BMN 110

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: MPS IV A, Mucopolysaccharidosis IVA | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-09-30